Strategic Planning
Business Development

Need
• In increasingly competitive biologics market, major supplier wished to divest a large number of plasma collection centers to reduce costs

Approach
• Guided executive team to develop criteria for identifying potential buyers who were not direct competitors
• Facilitated deal by selecting collection centers for divestment that had FDA and International licenses and good inspection records
• Identified potential buyer in the business of supplying source plasma to product development companies
• Negotiated and drafted Asset Purchase Agreement, Promissory Note, and Guaranty instruments

Benefits
• Client realized reduced costs of $20 million dollars
• Large up-front payment received in conjunction with sale of centers; deal secured with promissory note for payment of principal over a five year period backed by personal assets of purchasers and return from centers in case of default